Delivery Order SPE2DB22D3401-SPE2DB25FT3HP
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,347,007 units of DALVANCE 500 MG VIALS. The $7,058.54 firm fixed price delivery order has a completion date of May 27, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,270.48 delivery order contract to Amerisourcebergen Drug Corp for the supply of DALVANCE 500 MG VIALS pharmaceutical products. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities from the vendor to support military treatment programs and facilities worldwide....
- This federal contract award, valued at $6,474.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of February 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $9,336.15 firm fixed-price delivery order is for the supply of 4566749422 units of the antibiotic drug DALVANCE 500 MG VIALS, with a completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,585.12 firm fixed-price delivery order is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award, valued at $7,607.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, and has a completion date of February 18, 2025. This contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,090.15 firm fixed-price delivery order is for the supply of 4,567,894,030 units of DALVANCE 500 MG vials. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.56 firm fixed-price delivery order, identified as SPE2DB20D1100|SPE2DB25FB8K3, is for the supply of 4,567,976,431 units of the medication DALVANCE 500 MG VIALS. The contract has no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) vehicle,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,445.50, is for the delivery of DALVANCE 500 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of DALVANCE 500 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $7,837.15, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 17, 2025. It is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT3HPDelivery Order
This federal contract award, valued at $4,423.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,013,579 units of the medication DALVANCE 500 MG VIALS, with a performance period ending on April 24, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This latest award is likely a specific delivery order under that larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/23/25 |